Abstract
Objective
The purpose of this study was to analyze the occurrence characteristics, clinical manifestations, medication distribution, and incidence of drug-induced arrhythmias in a real-world inpatient population.
Methods
According to the inclusion and exclusion criteria as well as the ADR evaluation criteria, we retrospectively evaluated hospitalized patients in 2019 using the arrhythmia module of the Adverse Drug Event Active Surveillance and Assessment System-II (ADE-ASAS-II). A detailed analysis was performed on the demographic data, ADR manifestations, and medication distribution of 2097 patients with drug-induced arrhythmias and QT interval prolongation.
Results
Of the 167,546 hospitalized patients, there were 1809 cases of drug-induced arrhythmias, with an incidence of 1.08%. The ADRs in 45.35% of positive patients occurred within 3 days after medication administration, and 46.73% of the patients were 65 years old or older. The predominant ADRs identified in this study were extrasystole, tachycardia, and QT interval prolongation, of which the incidence was 0.20%. Levofloxacin was the most involved drug, and levofloxacin-associated rates of incidence of arrhythmia and QT interval prolongation were 1.24% and 0.44%, respectively. The risk factors for drug-induced arrhythmias were male sex, advanced age, emaciation, obesity, and underlying illnesses such as cardiovascular diseases, diabetes mellitus, cerebrovascular diseases, and hepatic and renal inadequacy (P < 0.05).
Conclusion
The incidence of drug-induced arrhythmias was in the range of common, while QTc interval prolongation was occasional. It is necessary to pay attention to patients with risk factors.
Similar content being viewed by others
Availability of data and materials
The data used to support the findings of this study are available upon reasonable request from the authors.
References
Bian R, Yuan J, Xu H (2012) The case-control study of the influencing factors of drug induced arrhythmias. Chin J Pharmacoepidemiol 21(10):477–479
Song W, Liu T (2020) Interpretation of the 2020 American Heart Association scientific statement on drug-induced arrhythmias. Chin J Evid Based Cardiovasc Med 12(11):1281–1282
Tisdale JE, Chung MK, Campbell KB et al (2020) Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation 142(15):e214–214e233
Vanneman MW, Madhok J, Weimer JM et al (2021) Perioperative implications of the 2020 American Heart Association scientific statement on drug-induced arrhythmias-a focused review. J Cardiothorac Vasc Anesth 36(4):952–961
Moreland-Head LN, Coons JC, Seybert AL et al (2021) Use of disproportionality analysis to identify previously unknown drug-associated causes of cardiac arrhythmias using the Food and Drug Administration Adverse Event Reporting System (FAERS) database. J Cardiovasc Pharmacol Ther 26(4):341–348
Kong X, Guo D, Liu S et al (2021) Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: a matched case-control study. Br J Clin Pharmacol 87(11):4304–4312
Yu C, Guo D, Yao C et al (2021) Development and validation of a nomogram for predicting drug-induced acute kidney injury in hospitalized patients: a case-control study based on propensity-score matching. Front Pharmacol 12:657853
Liu S, Guo D, Kong X et al (2021) Analysis of the characteristics and risk factors of suspected drug-induced allergic reactions in 201299 hospitalized patients. Chin J Pharmacoepidemiol 30(06):382–387
Guo D, Yu C (2021) Expert consensus on automated surveillance and evaluation of clinical medication risk based on hospital information system data. Chin J Drug Appl Mon 18(5):277–287
Guo H, Guo D, Gao A et al (2022) Establishment and validation of automatic monitoring module for drug-induced arrhythmia based on data of HIS. Chin J Drug Appl Mon 19(3):176–181
Yu C, Guo D, Yao C et al (2020) Clinical characteristics of hospitalized patients with drug-induced acute kidney injury and associated risk factors: a case-control study. Biomed Res Int 2020:9742754
Li B, Gao R, Li R et al (2014) Causal determination of the adverse events and adverse drug reactions in drug clinical trials. Chin J New Drugs 23(12):1465–1470
Arnar DO, Mairesse GH, Boriani G et al (2019) Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace 21(6):844–845
Schwartz PJ, Woosley RL (2016) Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol 67(13):1639–1650
Vlachos K, Georgopoulos S, Efremidis M et al (2016) An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol 9(1):117–127
Trinkley KE, Rlii P, Lien H et al (2013) QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 29(12):1719–1726
Klotzbaugh RJ, Martin A, Turner JR (2020) Drug-induced proarrhythmia: discussion and considerations for clinical practice. J Am Assoc Nurse Pract 32(2):1–7
Tong R, He Z, Cheng M et al (2020) Effects of levofloxacin on QTc interval of the patients with type 2 diabetes mellitus and infection. Pharm Clin Res 28(02):110–112
Guo H, Guo D, Liu S et al (2021) Analysis of 1 439 cases of drug-induced arrhythmia. Chin J Pharmacoepidemiol 30(3):181–186
Bulletin DAT (2016) QT interval and drug therapy. BMJ 353:i2732
Lee A, Pickham D (2016) Basic cardiac electrophysiology and common drug-induced arrhythmias. Crit Care Nurs Clin North Am 28(3):357
Lapi F, Wilchesky M, Kezouh A et al (2012) Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 55(11):1457–1465
Gorelik E, Masarwa R, Perlman A et al (2019) Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis. Drug Saf 42(4):529–538
Shojaei L, Ruzbahani M, Khajavian S et al (2020) Analysis of QTc Interval during levofloxacin prescription in cardiac patients with pneumonia. Curr Drug Saf 15(2):111–116
Alexandre J, Moslehi JJ, Bersell KR et al (2018) Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Pharmacol Ther 189:89–103
Tricco AC, Soobiah C, Blondal E et al (2015) Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med 13:142
van Mourik MS, Troelstra A, van Solinge WW et al (2013) Automated surveillance for healthcare-associated infections: opportunities for improvement. Clin Infect Dis 57(1):85–93
Chen C, Jia W, Guo D et al (2020) Development of a computer-assisted adverse drug events alarm and assessment system for hospital inpatients in China. Ther Innov Regul Sci 54(1):32–41
Hu P, Guo D, Jia W et al (2018) Intelligentialized real-time surveillance study on adverse drug reactions caused by cinepazide maleate. Chin J Drug Appl Mon 15(2):92–95
Funding
This study was supported by the Key Project of Military Medical Innovation Project in 2017 (No. 17CXZ010) and “the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs” commissioned by the Chinese Association of Research Hospitals (No. Y2021FH-YWPJ01).
Author information
Authors and Affiliations
Contributions
HG: conception, design, data collection, analysis of data, drafting, and revision of manuscript. DG: conception, design, interpretation of results, and critical revision of manuscript. HG and PL: statistics and analysis of data and interpretation of results. AG and PZ review positive cases. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethical approval
This study was approved by the Ethics Committee of Chinese PLA General Hospital (S2018-054–01). All patient data were kept strictly confidential.
Consent for publication
All authors agree to publish in the journal “European Journal of Clinical Pharmacology”.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guo, H., Li, P., Guo, D. et al. Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients. Eur J Clin Pharmacol 79, 759–765 (2023). https://doi.org/10.1007/s00228-023-03492-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-023-03492-6